| CAS NO: | 137-58-6 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 1g | 电议 |
| 2g | 电议 |
| 5g | 电议 |
| 10g | 电议 |
| 25g | 电议 |
| 50g | 电议 |
| Molecular Weight (MW) | 234.34 |
|---|---|
| Formula | C14H22N2O |
| CAS No. | 137-58-6 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility (In vitro) | DMSO: 47 mg/mL (200.6 mM) |
| Water: 9 mg/mL (38.4 mM) | |
| Ethanol: 47 mg/mL (200.6 mM) | |
| Other info | Chemical Name: 2',6'-Acetoxylidide, 2-(diethylamino)- InChi Key: NNJVILVZKWQKPM-UHFFFAOYSA-N InChi Code: InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17) SMILES Code: O=C(NC1=C(C)C=CC=C1C)CN(CC)CC |
| Synonyms | NSC 40030; Alphacaine; NSC-40030; NSC40030 |
| In Vitro | In vitro activity: Lidocaine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of>32 μM. |
|---|---|
| In Vivo | Lidocaine (Lignocaine) causes completely reversible tail nerve block in rats. Mechanical nociception block produced by lidocaine has slower onset and faster recovery compared with thermal nociception block. |
| Animal model | Rats |
| Formulation & Dosage | N/A |
| References | Acta Anaesthesiol Scand. 2015 Jan;59(1):47-55. |
m.cnreagent.com